BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11573107)

  • 1. Diagnosis and classification of inflammatory bowel disease.
    Fishman M
    Can J Gastroenterol; 2001 Sep; 15(9):627-8. PubMed ID: 11573107
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.
    Levine A; Griffiths A; Markowitz J; Wilson DC; Turner D; Russell RK; Fell J; Ruemmele FM; Walters T; Sherlock M; Dubinsky M; Hyams JS
    Inflamm Bowel Dis; 2011 Jun; 17(6):1314-21. PubMed ID: 21560194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What histologic features best differentiate Crohn's disease from ulcerative colitis?
    Geboes K
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S168-9. PubMed ID: 18816725
    [No Abstract]   [Full Text] [Related]  

  • 4. Colonoscopic biopsies in colitis.
    Bartram CI; Talbot IC
    Abdom Imaging; 1995; 20(4):384-6. PubMed ID: 7549752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Undefined chronic colitis with its patho-histologic differentiation from Crohn disease and ulcerative colitis].
    von Herbay A; Sinn P; Otto HF
    Z Gastroenterol Verh; 1989 Jul; 24():22-5. PubMed ID: 2474961
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathology of inflammatory bowel disease.
    Gramlich T; Petras RE
    Semin Pediatr Surg; 2007 Aug; 16(3):154-63. PubMed ID: 17602970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of chronic inflammatory bowel disease in children.
    Domizio P
    Baillieres Clin Gastroenterol; 1994 Mar; 8(1):35-63. PubMed ID: 8003743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological features of inflammatory bowel disease in childhood.
    Coulson WF
    Semin Pediatr Surg; 1994 Feb; 3(1):8-14. PubMed ID: 8062053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsule endoscopy may reclassify pediatric inflammatory bowel disease: a historical analysis.
    Cohen SA; Gralnek IM; Ephrath H; Saripkin L; Meyers W; Sherrod O; Napier A; Gobin T
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):31-6. PubMed ID: 18607266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Inflammatory Bowel Disease from Formalin-Fixed, Paraffin-Embedded Tissue Biopsies via Imaging Mass Spectrometry.
    Klein O; Fogt F; Hollerbach S; Nebrich G; Boskamp T; Wellmann A
    Proteomics Clin Appl; 2020 Nov; 14(6):e1900131. PubMed ID: 32691971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disaccharidase activity in children with inflammatory bowel disease.
    Wiecek S; Wos H; Radziewicz Winnicki I; Komraus M; Grzybowska Chlebowczyk U
    Turk J Gastroenterol; 2014 Apr; 25(2):185-91. PubMed ID: 25003680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha-2A (roferon) as a treatment of inflammatory bowel disease in children and adolescents.
    Hadziselimovic F; Schaub U; Emmons LR
    Adv Exp Med Biol; 1995; 371B():1323-6. PubMed ID: 7502809
    [No Abstract]   [Full Text] [Related]  

  • 13. Numerical taxonomy and discriminant analysis applied to non-specific colitis.
    Jones JH; Lennard-Jones JE; Morson BC; Chapman M; Sackin MJ; Sneath PH; Spicer CC; Card WI
    Q J Med; 1973 Oct; 42(168):715-32. PubMed ID: 4606853
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric inflammatory bowel disease.
    Antonioli DA
    Pediatr Dev Pathol; 2005; 8(1):2-19. PubMed ID: 15717115
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and pathological aspects of inflammatory bowel disease.
    Marteau P
    Nestle Nutr Workshop Ser Clin Perform Programme; 1999; 2():83-92. PubMed ID: 11490630
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease.
    Algaba A; Linares PM; Fernández-Contreras ME; Ordoñez A; Trápaga J; Guerra I; Chaparro M; de la Poza G; Gisbert JP; Bermejo F
    J Crohns Colitis; 2013 Dec; 7(11):e569-79. PubMed ID: 23642997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of Montreal classification in different clinical and serological IBD subtypes.
    Mokrowiecka A; Kumor A; Jakubczyk E; Pietruczuk M; Malecka-Panas E
    Hepatogastroenterology; 2010; 57(101):787-93. PubMed ID: 21033230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Histology in Determining Disease Activity, Treatment, and Prognosis: Are We There yet?
    Salem MS; Melmed GY
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):437-446. PubMed ID: 31078246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF-20: FGFs--they keep growing and growing and growing!
    Houchen CW
    Inflamm Bowel Dis; 2003 Mar; 9(2):133. PubMed ID: 12769450
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution and density of TNF immunoreactivity in chronic inflammatory bowel disease.
    Murch SH; Braegger CP; Walker-Smith JA; MacDonald TT
    Adv Exp Med Biol; 1995; 371B():1327-30. PubMed ID: 7502810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.